Principal, Venture Investments
- Focus: Consumer Health
- Based in New York, NY
- Fun fact: Conquered his fear of heights by skydiving
Based in New York City, Anurag has extensive experience analyzing and advising companies at various stages in their growth cycle across industries. As Principal, Venture Investments of Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Anurag works closely with JJDC portfolio companies to tackle challenges that companies face as they try to commercialize and scale their innovations, establish successful business models, and attain the right strategic exit.
Previously, Anurag was the Global Head of Strategic Transactions within the Consumer Health Business Development team at Johnson & Johnson, where he led acquisitions, equity investments and other strategic transactions. During his four years with the group, he was involved in a number of key transactions, including the acquisition of Dr Ci:Labo brand and Zarbee’s Naturals in 2018 and OGX brand in 2016. In 2019, Anurag additionally acted as the Interim Head of JLABS@NYC.
Prior to joining Johnson & Johnson, Anurag spent close to a decade in the Mergers & Acquisitions Group within the Investment Banking Division at Credit Suisse in New York, where he advised on over $60 billion of announced acquisitions, divestitures, joint ventures, corporate restructurings and takeover defense transactions across various industry verticals. Anurag started his career in Product Development at Oracle Corporation.
Anurag holds a B.Tech. in Mechanical Engineering from the Indian Institute of Technology in New Delhi, an MS in Industrial Engineering & Operations Research from the University of Florida and an MBA from the University of Chicago Booth School of Business.